186 related articles for article (PubMed ID: 22129185)
21. [A clinicopathological study on carcinoma of the renal pelvis and ureter].
Hashimoto H; Saga Y; Tokumitsu M; Yamaguchi S; Morikawa M; Yachiku S
Hinyokika Kiyo; 1997 Oct; 43(10):707-12. PubMed ID: 9395905
[TBL] [Abstract][Full Text] [Related]
22. Renal neuroendocrine tumours: a clinicopathological study.
Lane BR; Chery F; Jour G; Sercia L; Magi-Galluzzi C; Novick AC; Zhou M
BJU Int; 2007 Nov; 100(5):1030-5. PubMed ID: 17784891
[TBL] [Abstract][Full Text] [Related]
23. Lipoid-cell variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of five cases.
Leroy X; Gonzalez S; Zini L; Aubert S
Am J Surg Pathol; 2007 May; 31(5):770-3. PubMed ID: 17460462
[TBL] [Abstract][Full Text] [Related]
24. Transitional cell carcinomas of the renal pelvis and the ureter: comparative demographic characteristics, pathological grade and stage and 5-year survival in a Taiwanese population.
Tan LB; Chang LL; Cheng KI; Huang CH; Kwan AL
BJU Int; 2009 Feb; 103(3):312-6. PubMed ID: 18782312
[TBL] [Abstract][Full Text] [Related]
25. Urothelial carcinoma of the upper urinary tract: comparison between the WHO/ISUP 1998 consensus classification and WHO 1999 classification system.
Holmäng S; Johansson SL
Urology; 2005 Aug; 66(2):274-8. PubMed ID: 16098355
[TBL] [Abstract][Full Text] [Related]
26. [Clinical study on renal pelvic and ureteral tumors].
Okumura A; Yokoyama T; Muraishi Y; Nagakawa O; Sakamoto M; Kazama T; Fuse H; Katayama T
Hinyokika Kiyo; 1994 Sep; 40(9):777-80. PubMed ID: 7801838
[TBL] [Abstract][Full Text] [Related]
27. Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients.
Lughezzani G; Jeldres C; Isbarn H; Sun M; Shariat SF; Alasker A; Pharand D; Widmer H; Arjane P; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
Eur J Cancer; 2009 Dec; 45(18):3291-7. PubMed ID: 19615885
[TBL] [Abstract][Full Text] [Related]
28. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
Veras E; Deavers MT; Silva EG; Malpica A
Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
[TBL] [Abstract][Full Text] [Related]
29. Metastatic renal cell carcinoma to the bladder: a clinicopathologic and immunohistochemical study.
Sim SJ; Ro JY; Ordonez NG; Park YW; Kee KH; Ayala AG
Mod Pathol; 1999 Apr; 12(4):351-5. PubMed ID: 10229498
[TBL] [Abstract][Full Text] [Related]
30. [A clinicopathological evaluation of prognostic factors of urothelial tumors of the renal pelvis and ureter].
Oikawa T; Nomura H; Kinsui H; Hamano S; Suzuki N; Tanaka M; Murakami S; Nokubi M; Suzuki Y
Hinyokika Kiyo; 2001 Apr; 47(4):237-40. PubMed ID: 11411096
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological and immunohistochemical features of oral spindle cell carcinoma.
Romañach MJ; Azevedo RS; Carlos R; de Almeida OP; Pires FR
J Oral Pathol Med; 2010 Apr; 39(4):335-41. PubMed ID: 20002980
[TBL] [Abstract][Full Text] [Related]
32. [A clinical study on transitional cell carcinoma of renal pelvis and ureter].
Ito T; Miyao H; Ito S; Nishijima T
Hinyokika Kiyo; 1993 Aug; 39(8):701-4. PubMed ID: 8379470
[TBL] [Abstract][Full Text] [Related]
33. [Synchronous tumors in right renal pelvis and left ureter].
Morikawa M; Nakata Y; Tokunaka S; Inada F; Takamura T; Yachiku S; Kondoh F
Hinyokika Kiyo; 1985 Apr; 31(4):655-63. PubMed ID: 4036741
[TBL] [Abstract][Full Text] [Related]
34. P53 expression in small cell carcinoma of the urinary bladder: biological and prognostic implications.
Wang X; Jones TD; Maclennan GT; Yang XJ; Lopez-Beltran A; Eble JN; Koch MO; Lin H; Baldridge LA; Tretiakova M; Cheng L
Anticancer Res; 2005; 25(3B):2001-4. PubMed ID: 16158936
[TBL] [Abstract][Full Text] [Related]
35. Upper urinary tract tumors with nontransitional histology: a single-center experience.
Busby JE; Brown GA; Tamboli P; Kamat AM; Dinney CP; Grossman HB; Matin SF
Urology; 2006 Mar; 67(3):518-23. PubMed ID: 16527570
[TBL] [Abstract][Full Text] [Related]
36. Expression and prognostic value of CD44 isoforms in transitional cell carcinoma of renal pelvis and ureter.
Masuda M; Takano Y; Iki M; Makiyama K; Noguchi S; Hosaka M
J Urol; 1999 Mar; 161(3):805-8; discussion 808-9. PubMed ID: 10022688
[TBL] [Abstract][Full Text] [Related]
37. Combined small-cell and transitional cell carcinoma of the renal pelvis. A light microscopic, immunohistochemical, and ultrastructural study of a case with literature review.
Guillou L; Duvoisin B; Chobaz C; Chapuis G; Costa J
Arch Pathol Lab Med; 1993 Mar; 117(3):239-43. PubMed ID: 8382912
[TBL] [Abstract][Full Text] [Related]
38. [Clinical review of conservative management of upper urinary tract transitional cell carcinoma].
Oka H; Shiraishi Y; Negoro H; Iwamura H; Moroi S; Soeda A; Takeuchi H; Kawakita M
Hinyokika Kiyo; 2006 Apr; 52(4):249-53. PubMed ID: 16686350
[TBL] [Abstract][Full Text] [Related]
39. Primary carcinoma of the renal pelvis and ureter. Evaluation of clinical and pathologic features.
Strobel SL; Jasper WS; Gogate SA; Sharma HM
Arch Pathol Lab Med; 1984 Sep; 108(9):697-700. PubMed ID: 6547821
[TBL] [Abstract][Full Text] [Related]
40. [Synchronous multiple carcinosarcoma of the renal pelvis and ureter: a case report].
Ishimura H; Momose A; Narita S; Kurotaki H
Hinyokika Kiyo; 2010 Jul; 56(7):381-4. PubMed ID: 20724812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
